How Pharma Can Turn Data into Insights: Effectively Leveraging Pharma and Market Access Data
INSIGHTS
Strategic and tactical insights on pharmaceutical market access topics spanning distribution, pharmacy, and access and affordability.
- Jun 6, 2023
Market Access POV: ICER and Specialty Drug Coverage
- May 23, 2023
Good vs. Excellent: How to Maximize Your 3PL Partnership
- May 17, 2023
Key Takeaways from the 2023 Asembia Specialty Pharmacy Summit
- May 9, 2023
How Manufacturers Can Optimize Hub Services
- Apr 27, 2023
Specialty Pharmacy Services Fair Market Value Benchmark Report
- Apr 25, 2023
Conversation Starters to Drive Impactful Discussions with Specialty Pharmacies
- Apr 11, 2023
3PL Health Checks Generate Savings for Manufacturers: Here's How to Begin
- Mar 28, 2023
3 Market Access Takeaways from SXSW 2023
- Dec 19, 2022
Well-designed Access and Affordability Programs can be a Key Differentiator for Pharma Companies
- Dec 14, 2022
Effectively Navigate the Rapidly Evolving Pharmacy Market
- Dec 9, 2022
How Effective Product Distribution Strategies Maximize the Pharmaceutical Supply Chain
- Oct 10, 2022
Webinar Archive: 11 Market Access Questions to Address Prior to Launching Your First Specialty Drug
- Sep 23, 2022
Best Practices for Improving Program Performance Through Well-Managed SP Relationships
- Aug 30, 2022
Control vs. Access: Why Clinical Characteristics Should Guide Specialty Pharmacy Strategy
- Aug 15, 2022
How Equitable is Your Pharmacy Dispensing Strategy?
- Jun 27, 2022
How to Prepare for DSCSA D-Day
- May 23, 2022
Effective and Practical Ways to Impact Health Inequity Now
- Apr 27, 2022
11 Market Access Questions to Address Prior to Launching Your First Specialty Drug
- Apr 19, 2022
How Quality in Patient Services Programs Can be a Powerful Differentiator for Pharma and Biotech